학술논문

First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis
Document Type
Article
Source
In Annals of Oncology August 2021 32(8):983-993
Subject
Breast tumors
Language
ISSN
0923-7534